Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Bo Yu"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Thymic carcinoma (TC) is an uncommon type of thymic epithelial tumors. Patients with relapsed or refractory TCs have a poor prognosis. Immune checkpoint inhibitor monotherapy can be applied as a second-line treatment for such cases. This study report
Externí odkaz:
https://doaj.org/article/dae94c98f3bd4af7994e6ad314b247ed
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Sarcomatoid renal cell carcinoma (SRCC), a manifestation of sarcomatoid dedifferentiation in renal cell carcinoma, is characterized by elevated invasiveness and a grim prognosis. Typically, SRCC patients present with advanced or metastatic conditions
Externí odkaz:
https://doaj.org/article/b4e715397ded469883cf7d9f31871a03
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Secondary neoplasms of the testes from solid tumors are rare and usually present as a painless mass. Metastatic cecum signet-ring cell cancer of the testis is extremely rare. The orchioncus usually shows hypervascularity on color Doppler ultrasound.
Externí odkaz:
https://doaj.org/article/ca582088114d4c75b8cd78004b2a4d19
Autor:
Jiayu Li, Xuhui Yuan, Cong Ma, Junhong Li, Gaoyang Qu, Bo Yu, Feng Cai, Yuanxiang Peng, Lang Liu, Duo Zeng, QuanHui Jiao, Jiongfeng Zhang, Xiaohui Luo, Qi Liao, Xiao-Bin Lv
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveRecent knowledge concerning the significance of long non-coding RNA (lncRNA)-mediated ceRNA networks provides new insight into their possible roles as specific biomarkers for the treatment of osteosarcoma (OS). Thus, this study aims to clari
Externí odkaz:
https://doaj.org/article/2122c12f949b4ed0a8d623a7cf55a1fe
Autor:
Xiangling Wang, Ting Wang, Yunxia Chu, Jie Liu, Cuihua Yi, Xuejun Yu, Yonggang Wang, Tianying Zheng, Fangli Cao, Linli Qu, Bo Yu, Huayong Liu, Fei Ding, Shuang Wang, Xiangbo Wang, Jing Hao, Xiuwen Wang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundFor patients who have contraindications to or have failed checkpoint inhibitors, chemotherapy remains the standard second-line option to treat non-oncogene-addicted advanced non-small cell lung cancer (NSCLC). This study aimed to investigat
Externí odkaz:
https://doaj.org/article/d239b2f4dd5840ba989d82b6e52b95b9
Case Report: Molecular Profiling Assists in the Diagnosis and Treatment of Cancer of Unknown Primary
Autor:
Bo Yu, Qifeng Wang, Xin Liu, Silong Hu, Liangping Zhou, Qinghua Xu, Yifeng Sun, Xichun Hu, Zhiguo Luo, Xiaowei Zhang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundFor cancer of unknown primary (CUP), non-selective empiric chemotherapy is usually used. However, patients suffering from CUP are generally assumed to have a dismal prognosis with median overall survival of less than 1 year. Therefore, clin
Externí odkaz:
https://doaj.org/article/6a5b9f4cdd314d049080b52a3c54b30d
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
It has been shown that circular RNA XPO1 (circXPO1) is involved in cancer (e.g., lung adenocarcinoma and osteosarcoma) progression by sponging microRNAs. Nevertheless, the role of circXPO1 and its interaction with microRNAs in prostate cancer remains
Externí odkaz:
https://doaj.org/article/e428e5e7e5564bacb77ab4e5f2c45a49
Autor:
Bo Yu, Jizhe Wang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundLaryngeal cancer (LaC) remains one of the most common tumors of the respiratory tract with higher incidence in men than in women. The larynx is a small but vital organ on the neck. The dysfunction of the larynx can cause serious health prob
Externí odkaz:
https://doaj.org/article/3a67a9792bea47babccc431e637fe256
Autor:
Yuan Li, Xiaolan Zhang, Yan Gao, Chunliang Shang, Bo Yu, Tongxia Wang, Junyan Su, Cuiyu Huang, Yu Wu, Hongyan Guo, Chunfang Ha
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
BackgroundHigh grade serous ovarian cancer (HGSOC) is the most common subtype of ovarian cancer. Although platinum-based chemotherapy has been the cornerstone for HGSOC treatment, nearly 25% of patients would have less than 6 months of interval since
Externí odkaz:
https://doaj.org/article/53f03e0f3d3a4503a3dd84186c0d4c7e
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Glioma is the most common malignant tumor of the central nervous system with high morbidity and mortality. Circular RNAs (circRNAs) are abundant non-coding RNAs, which contribute to tumor progression by competing with other endogenous RNAs such as mi
Externí odkaz:
https://doaj.org/article/9e540403fb2b4cf88ea8c24fb570c8f8